Mechanism of Action: Endothelin Receptor Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Endothelin Receptor Antagonists
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sigmapharm Labs Llc | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208354-002 | Apr 10, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cipla | AMBRISENTAN | ambrisentan | TABLET;ORAL | 210715-001 | Apr 26, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Apotex | AMBRISENTAN | ambrisentan | TABLET;ORAL | 210701-002 | May 19, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cipla | AMBRISENTAN | ambrisentan | TABLET;ORAL | 210715-002 | Apr 26, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mylan | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208441-001 | Mar 28, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus Pharms | AMBRISENTAN | ambrisentan | TABLET;ORAL | 210058-001 | Mar 28, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |